Zobrazeno 1 - 10
of 572
pro vyhledávání: '"Michael H, Baumann"'
Autor:
Marija Ilic, Julian Maier, Marion Holy, Kathrin Jaentsch, Matthias E. Liechti, Gert Lubec, Michael H. Baumann, Harald H. Sitte, Dino Luethi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/c9ebc5a1343c4313bf4cb6716348a1b8
Autor:
Michael J. Espiritu, Jonathan K. Taylor, Christopher K. Sugai, Parashar Thapa, Nikolaus M. Loening, Emma Gusman, Zenaida G. Baoanan, Michael H. Baumann, Jon-Paul Bingham
Publikováno v:
Marine Drugs, Vol 21, Iss 2, p 61 (2023)
χ-Conotoxins are known for their ability to selectively inhibit norepinephrine transporters, an ability that makes them potential leads for treating various neurological disorders, including neuropathic pain. PnID, a peptide isolated from the venom
Externí odkaz:
https://doaj.org/article/ae427a0baa8a42f0ad484d5d02a4dc23
Autor:
Grant C. Glatfelter, Marilyn Naeem, Duyen N. K. Pham, James A. Golen, Andrew R. Chadeayne, David R. Manke, Michael H. Baumann
Publikováno v:
ACS Pharmacology & Translational Science. 6:567-577
Autor:
Michael R. Chojnacki, Eric B. Thorndike, John S. Partilla, Kenner C. Rice, Charles W. Schindler, Michael H. Baumann
Publikováno v:
J Pharmacol Exp Ther
Synthetic cathinones are a class of new psychoactive substances that display psychomotor stimulant properties, and novel cathinone analogs continue to emerge in illicit drug markets worldwide. The aim of the present study was to characterize the phar
Autor:
Marija Ilic, Marion Holy, Kathrin Jaentsch, Matthias E. Liechti, Gert Lubec, Michael H. Baumann, Harald H. Sitte, Dino Luethi
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
High-affinity monoamine transporters are targets for prescribed medications and stimulant drugs of abuse. Therefore, assessing monoamine transporter activity for candidate medications and newly-emerging drugs of abuse provides essential information f
Externí odkaz:
https://doaj.org/article/ad760756037c4f5fa408d93286f8432e
Autor:
Felix P Mayer, Marco Niello, Daniela Cintulova, Spyridon Sideromenos, Julian Maier, Yang Li, Simon Bulling, Oliver Kudlacek, Klaus Schicker, Hideki Iwamoto, Fei Deng, Jinxia Wang, Marion Holy, Rani Katamish, Walter Sandtner, Yulong Li, Daniela Pollak, Randy D Blakely, Marko Mihovilovic, Michael H Baumann, Harald H Sitte
Publikováno v:
Molecular Psychiatry. 28:722-732
Increasing extracellular levels of serotonin (5-HT) in the brain ameliorates symptoms of depression and anxiety-related disorders, e.g. social phobias and post-traumatic stress disorder. Recent evidence from preclinical and clinical studies establish
Autor:
Shelby A. McGriff, Michael R. Chojnacki, Eric B. Thorndike, Kenner C. Rice, Michael H. Baumann, Charles W. Schindler
Publikováno v:
Psychopharmacology. 239:3723-3730
Synthetic phenethylamine (PEA) analogs, such as β-methylphenethylamine (BMPEA) and N,α-diethylphenethylamine (DEPEA), are often found in dietary supplements, despite regulations prohibiting their sale. PEA analogs are structurally related to amphet
Autor:
Marta, Concheiro, Steven, Towler, Joshua S, Elmore, Michael R, Chojnacki, Teeshavi, Acosta, Masaki, Suzuki, Kenner C, Rice, Michael H, Baumann
Publikováno v:
Current Pharmaceutical Design. 28:2653-2663
Background: MDPV (3,4-methylenedioxypyrovalerone) is a synthetic stimulant that blocks transmitter uptake at transporters for dopamine and norepinephrine. Less is known about MDPV pharmacokinetics, especially with respect to brain concentrations of t
Autor:
Grant C. Glatfelter, Duyen N. K. Pham, Donna Walther, James A. Golen, Andrew R. Chadeayne, Michael H. Baumann, David R. Manke
Publikováno v:
ACS Omega. 7:24888-24894
Aeruginascin (4-phosphoryloxy
Autor:
Charles W. Schindler, Shelby A. McGriff, Eric B. Thorndike, Li Chen, Donna Walther, Kenner Rice, Lei Shi, Michael H. Baumann
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Cardiovascular Pharmacology.